Industry Groups Push For Exemptions To Med Tech 232 Tariffs

By Margaret Spiegelman, Jessica Karins / October 21, 2025 at 5:13 PM

Representatives of major industry groups are pressing the administration to exclude key U.S. partners from potential new national security tariffs on a raft of medical supplies and devices, warning that broad-based levies could lead to price increases for products like pacemakers, MRI machines, cancer diagnostics and personal protective equipment, among others.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.